Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Mydecine Innovations Group Inc. (MYCOF)

Compare
0.0050
+0.0016
+(47.06%)
At close: April 17 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
7.4930
2.6170
Gross Profit
--
--
--
7.4930
2.6170
Operating Expense
7,034.8570
9,548.4000
15,971.0010
22,691.6290
11,461.7730
Operating Income
-7,034.8570
-9,548.4000
-15,971.0010
-22,684.1360
-11,459.1560
Net Non Operating Interest Income Expense
-1,684.7730
-1,302.7380
-911.5940
-205.2670
-182.8660
Other Income Expense
-3,738.2930
-10,095.8940
1,137.4980
-693.5080
-15,233.9840
Pretax Income
-12,457.9230
-20,947.0320
-15,745.0970
-23,582.9110
-26,876.0060
Net Income Common Stockholders
-12,457.9230
-20,947.0320
-9,249.6920
-28,897.3990
-26,948.9450
Diluted NI Available to Com Stockholders
-12,457.9230
-20,947.0320
-9,249.6920
-28,897.3990
-26,948.9450
Basic EPS
-0.20
-0.68
-1.07
-6.17
-12.05
Diluted EPS
-0.20
-0.68
-1.07
-6.17
-12.05
Basic Average Shares
56,583.8510
30,696.9260
8,647.4710
4,681.7210
2,274.2850
Diluted Average Shares
56,583.8510
30,696.9260
8,647.4710
4,681.7210
2,274.2850
Total Expenses
7,034.8570
9,548.4000
15,971.0010
22,691.6290
11,461.7730
Net Income from Continuing & Discontinued Operation
-12,457.9230
-20,947.0320
-9,249.6920
-28,897.3990
-26,948.9450
Normalized Income
-12,468.9280
-14,573.7690
-17,188.7130
-23,272.3050
-11,666.0470
Interest Expense
1,684.7730
1,302.7380
911.5940
205.2670
182.8660
Net Interest Income
-1,684.7730
-1,302.7380
-911.5940
-205.2670
-182.8660
EBIT
-10,773.1500
-19,644.2940
-14,833.5030
-23,377.6440
-26,693.1400
EBITDA
-10,773.1490
-19,634.4180
-14,704.6420
-23,142.4670
-26,636.0600
Reconciled Depreciation
0.0010
9.8760
128.8610
235.1770
57.0800
Net Income from Continuing Operation Net Minority Interest
-12,457.9230
-20,947.0320
-15,745.0970
-23,582.9110
-26,876.0060
Total Unusual Items Excluding Goodwill
11.0050
-6,373.2630
1,443.6160
-310.6060
-15,209.9590
Total Unusual Items
11.0050
-6,373.2630
1,443.6160
-310.6060
-15,209.9590
Normalized EBITDA
-10,784.1540
-13,261.1550
-16,148.2580
-22,831.8610
-11,426.1010
12/31/2020 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers